Johnson & Johnson Presented neoadjuvant TAR-200 plus cetrelimab ... that included treatment with cetrelimab was being discontinued for not showing superiority to chemoradiation during a scheduled ...

During the past 20 years, the advent of neoadjuvant, primary ... compared with surgical resection with or without adjuvant treatment. Second, chemotherapy can act as a radiosensitizer, improving ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

By contrast, the CONTINUUM study used an EBV DNA concentration of at least 4000 copies per mL to define patients at high risk, and 50% of patients in Liu and colleagues' study had this concentration ...

Summary and Introduction Clinical Application—Disease Entities Theoretical Framework for Therapy−The 'Steel Paradigm' Conclusion References Theoretical Framework for Therapy−The 'Steel ...

The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable non–small cell lung cancer (NSCLC) in the neoadjuvant and adjuvant ...

Though it’s the most common skin condition in the United States, determining the best acne treatment for your skin is still challenging. Acne treatments include prescription medications ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2024. "I'm honored to join ...

Research has shown aspirin use to be associated with lower rates of metastasis for some patients.